JP2020523282A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2020523282A5 JP2020523282A5 JP2019552978A JP2019552978A JP2020523282A5 JP 2020523282 A5 JP2020523282 A5 JP 2020523282A5 JP 2019552978 A JP2019552978 A JP 2019552978A JP 2019552978 A JP2019552978 A JP 2019552978A JP 2020523282 A5 JP2020523282 A5 JP 2020523282A5
- Authority
- JP
- Japan
- Prior art keywords
- substituted
- aryl
- cycloheteroalkenyl
- cycloheteroalkyl
- arylalkenyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 0 Cc1n[n]cc1*CNc1nc2cc(S)ccc2[s]1 Chemical compound Cc1n[n]cc1*CNc1nc2cc(S)ccc2[s]1 0.000 description 39
- XYEKVCDZBKLYKQ-UHFFFAOYSA-N CC(C)c(cc1)cc2c1[nH]nc2 Chemical compound CC(C)c(cc1)cc2c1[nH]nc2 XYEKVCDZBKLYKQ-UHFFFAOYSA-N 0.000 description 1
- LGMLMQXUCJTHGH-UHFFFAOYSA-N CC(C)c1c[nH]nc1C(F)(F)F Chemical compound CC(C)c1c[nH]nc1C(F)(F)F LGMLMQXUCJTHGH-UHFFFAOYSA-N 0.000 description 1
- ASIFVGBIFBHPJO-KGKSHYRASA-N CCN(CC)CC(c(c1c(cc2)nc(/C(/C(C)=N)=C/N)c3c1CCCC3)c2NN)=C Chemical compound CCN(CC)CC(c(c1c(cc2)nc(/C(/C(C)=N)=C/N)c3c1CCCC3)c2NN)=C ASIFVGBIFBHPJO-KGKSHYRASA-N 0.000 description 1
- RNSHSZQPQQPZMD-UHFFFAOYSA-O CCc1c(C(C(C=C2)[NH3+])C=N)c2nc(C(CC2)=Cc3c2[nH]nc3N(C)CCO)c1CC=C Chemical compound CCc1c(C(C(C=C2)[NH3+])C=N)c2nc(C(CC2)=Cc3c2[nH]nc3N(C)CCO)c1CC=C RNSHSZQPQQPZMD-UHFFFAOYSA-O 0.000 description 1
- KVSVMTWPPWJVEM-UHFFFAOYSA-N CN(C)C(c1n[nH]cc1-c1c(CCCC2)c2c(c2c(cc3)[nH][n]c2)c3c1)=O Chemical compound CN(C)C(c1n[nH]cc1-c1c(CCCC2)c2c(c2c(cc3)[nH][n]c2)c3c1)=O KVSVMTWPPWJVEM-UHFFFAOYSA-N 0.000 description 1
- ARVUNNKSHDGHPF-UHFFFAOYSA-O CN(CCO)c1c[nH]c(cc2)c1c1c2nc(C(C(C2CC2)=N)=C[NH3+])c2c1CCCC2 Chemical compound CN(CCO)c1c[nH]c(cc2)c1c1c2nc(C(C(C2CC2)=N)=C[NH3+])c2c1CCCC2 ARVUNNKSHDGHPF-UHFFFAOYSA-O 0.000 description 1
- GJOOCAXPERKNMN-UHFFFAOYSA-N Cc(c(F)c1)ccc1O Chemical compound Cc(c(F)c1)ccc1O GJOOCAXPERKNMN-UHFFFAOYSA-N 0.000 description 1
- AHAMWENZZWAOED-UHFFFAOYSA-N Cc1c(c(CCC(C2)C(Nc3ccc(C=N)cc3)=O)c2c(C(CCC2)=CC=C2O)n2)c2ccc1NN Chemical compound Cc1c(c(CCC(C2)C(Nc3ccc(C=N)cc3)=O)c2c(C(CCC2)=CC=C2O)n2)c2ccc1NN AHAMWENZZWAOED-UHFFFAOYSA-N 0.000 description 1
- QJDSMZPLJZUCEO-UHFFFAOYSA-O NCC(c(c1c(cc2)nc(-c3c[nH]nc3C(F)(F)F)c3c1CCCC3)c2[NH3+])=N Chemical compound NCC(c(c1c(cc2)nc(-c3c[nH]nc3C(F)(F)F)c3c1CCCC3)c2[NH3+])=N QJDSMZPLJZUCEO-UHFFFAOYSA-O 0.000 description 1
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2022027439A JP2022081529A (ja) | 2017-03-29 | 2022-02-25 | キナーゼネットワークの阻害剤およびその使用 |
| JP2022150644A JP7668254B2 (ja) | 2017-03-29 | 2022-09-21 | キナーゼネットワークの阻害剤およびその使用 |
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762478069P | 2017-03-29 | 2017-03-29 | |
| US62/478,069 | 2017-03-29 | ||
| US201862616643P | 2018-01-12 | 2018-01-12 | |
| US62/616,643 | 2018-01-12 | ||
| PCT/US2018/024991 WO2018183586A1 (en) | 2017-03-29 | 2018-03-29 | Inhibitors of kinase networks and uses thereof |
Related Child Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022027439A Division JP2022081529A (ja) | 2017-03-29 | 2022-02-25 | キナーゼネットワークの阻害剤およびその使用 |
| JP2022150644A Division JP7668254B2 (ja) | 2017-03-29 | 2022-09-21 | キナーゼネットワークの阻害剤およびその使用 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2020523282A JP2020523282A (ja) | 2020-08-06 |
| JP2020523282A5 true JP2020523282A5 (cg-RX-API-DMAC7.html) | 2020-09-17 |
| JP7788208B2 JP7788208B2 (ja) | 2025-12-18 |
Family
ID=63677063
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019552978A Active JP7788208B2 (ja) | 2017-03-29 | 2018-03-29 | キナーゼネットワークの阻害剤およびその使用 |
| JP2022027439A Pending JP2022081529A (ja) | 2017-03-29 | 2022-02-25 | キナーゼネットワークの阻害剤およびその使用 |
| JP2022150644A Active JP7668254B2 (ja) | 2017-03-29 | 2022-09-21 | キナーゼネットワークの阻害剤およびその使用 |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022027439A Pending JP2022081529A (ja) | 2017-03-29 | 2022-02-25 | キナーゼネットワークの阻害剤およびその使用 |
| JP2022150644A Active JP7668254B2 (ja) | 2017-03-29 | 2022-09-21 | キナーゼネットワークの阻害剤およびその使用 |
Country Status (6)
| Country | Link |
|---|---|
| US (3) | US11040973B2 (cg-RX-API-DMAC7.html) |
| EP (2) | EP4233859A1 (cg-RX-API-DMAC7.html) |
| JP (3) | JP7788208B2 (cg-RX-API-DMAC7.html) |
| CN (1) | CN110662536B (cg-RX-API-DMAC7.html) |
| CA (1) | CA3056641A1 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2018183586A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3056641A1 (en) * | 2017-03-29 | 2018-10-04 | Purdue Research Foundation | Inhibitors of kinase networks and uses thereof |
| TWI802635B (zh) | 2018-01-18 | 2023-05-21 | 美商亞雷生物製藥股份有限公司 | 作為ｒｅｔ激酶抑制劑之經取代吡咯并[2,3-d]嘧啶化合物 |
| WO2019143994A1 (en) | 2018-01-18 | 2019-07-25 | Array Biopharma Inc. | Substituted pyrazolyl[4,3-c]pyridinecompounds as ret kinase inhibitors |
| CA3117710A1 (en) | 2018-12-11 | 2020-06-18 | Theravance Biopharma R&D Ip, Llc | Alk5 inhibitors |
| WO2021061823A1 (en) * | 2019-09-23 | 2021-04-01 | Boragen, Inc. | Chemical compounds |
| CA3160307A1 (en) | 2019-11-22 | 2021-05-27 | Theravance Biopharma R&D Ip, Llc | Substituted 1,5-naphthyridines or quinolines as alk5 inhibitors |
| CN113214294A (zh) * | 2020-06-10 | 2021-08-06 | 深圳铂立健医药有限公司 | 三环化合物、药物组合物及其应用 |
| US20230312562A1 (en) * | 2020-07-02 | 2023-10-05 | Purdue Research Foundation | Tetrahydro-3h-pyrazolo quinolone and tetrahydro-3h-pyrrolo[3,2-f]quinoline -containing compounds and uses thereof |
| CN116903594A (zh) * | 2022-04-20 | 2023-10-20 | 上海挚盟医药科技有限公司 | Rho相关蛋白激酶抑制剂及其制备和应用 |
| CN117186002A (zh) * | 2022-05-31 | 2023-12-08 | 江苏亚虹医药科技股份有限公司 | 7-氰基-8-羟基喹啉衍生物、其制备方法及其医药用途 |
| CN119301099A (zh) * | 2022-06-02 | 2025-01-10 | 普渡研究基金会 | 4-(3H-吡唑并[4,3-f]喹啉-7-基)-N-(2-(二甲基氨基)乙基)苯甲酰胺或异羟肟酸化合物、组合物及使用方法 |
| WO2024206164A1 (en) * | 2023-03-24 | 2024-10-03 | Purdue Research Foundation | 3H-PYRAZOLO[4.3:f] QUINOLINE-BASED COMPOUNDS AS STING ANTAGONISTS |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3947434A (en) * | 1973-06-06 | 1976-03-30 | Morton-Norwich Products, Inc. | 9-(P-phenylazoanilino)-7-methyl-1H-imidazo[4,5-f]quinolines |
| EP0187705A3 (en) * | 1985-01-08 | 1988-05-11 | Norwich Eaton Pharmaceuticals, Inc. | Imidazo(4,5-f)quinolines useful as immunomodulating agents |
| WO1993022317A1 (fr) | 1992-05-01 | 1993-11-11 | Kowa Co., Ltd. | Derive de quinoline ou son sel et medicament contenant ledit derive pour maladies cardiaques |
| US6228362B1 (en) * | 1992-08-21 | 2001-05-08 | Immunomedics, Inc. | Boron neutron capture therapy using pre-targeting methods |
| US7405320B2 (en) * | 1998-06-22 | 2008-07-29 | Immunomedics, Inc. | Therapeutic and diagnostic conjugates for use with multispecific antibodies |
| ES2391550T3 (es) | 1999-04-15 | 2012-11-27 | Bristol-Myers Squibb Company | Inhibidores cíclicos de la proteína tirosina quinasa |
| US20050080260A1 (en) * | 2003-04-22 | 2005-04-14 | Mills Randell L. | Preparation of prodrugs for selective drug delivery |
| US20050043233A1 (en) * | 2003-04-29 | 2005-02-24 | Boehringer Ingelheim International Gmbh | Combinations for the treatment of diseases involving cell proliferation, migration or apoptosis of myeloma cells or angiogenesis |
| US20060281771A1 (en) * | 2005-06-10 | 2006-12-14 | Baumann Christian A | Synergistic modulation of flt3 kinase using aminoquinoline and aminoquinazoline kinase modulators |
| EP1891067B1 (en) | 2005-06-17 | 2016-01-13 | Ligand Pharmaceuticals Incorporated | Androgen receptor modulator compounds and methods |
| AR057656A1 (es) * | 2005-07-01 | 2007-12-12 | Ligand Pharm Inc | Compuestos moduladores de receptores de androgeno y metodods relacionados |
| JPWO2011043359A1 (ja) | 2009-10-06 | 2013-03-04 | 協和発酵キリン株式会社 | 芳香族複素環化合物を含有する医薬 |
| AU2011331301A1 (en) | 2010-11-15 | 2013-05-23 | Katholieke Universiteit Leuven | Antiviral condensed heterocyclic compounds |
| EP3453710B1 (en) | 2014-09-17 | 2022-09-21 | Celgene Quanticel Research, Inc. | Histone demethylase inhibitors |
| WO2016112284A1 (en) | 2015-01-09 | 2016-07-14 | Genentech, Inc. | (piperidin-3-yl)(naphthalen-2-yl)methanone derivatives and related compounds as inhibitors of the histone demethylase kdm2b for the treatment of cancer |
| CA3056641A1 (en) * | 2017-03-29 | 2018-10-04 | Purdue Research Foundation | Inhibitors of kinase networks and uses thereof |
-
2018
- 2018-03-29 CA CA3056641A patent/CA3056641A1/en active Pending
- 2018-03-29 JP JP2019552978A patent/JP7788208B2/ja active Active
- 2018-03-29 CN CN201880034786.5A patent/CN110662536B/zh active Active
- 2018-03-29 WO PCT/US2018/024991 patent/WO2018183586A1/en not_active Ceased
- 2018-03-29 EP EP23176745.0A patent/EP4233859A1/en active Pending
- 2018-03-29 US US16/499,133 patent/US11040973B2/en active Active
- 2018-03-29 EP EP18776719.9A patent/EP3600287B1/en active Active
-
2021
- 2021-04-29 US US17/243,629 patent/US11891391B2/en active Active
-
2022
- 2022-02-25 JP JP2022027439A patent/JP2022081529A/ja active Pending
- 2022-09-21 JP JP2022150644A patent/JP7668254B2/ja active Active
-
2023
- 2023-12-21 US US18/392,204 patent/US12384782B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2020523282A5 (cg-RX-API-DMAC7.html) | ||
| JP2024009953A (ja) | ４’－ハロゲン含有ヌクレオチドおよびヌクレオシド治療組成物ならびにそれらに関連する使用 | |
| ES2665539T3 (es) | Derivados de benzamida para inhibir la actividad de ABL1, ABL2 y BCR-ABL1 | |
| RU2640582C2 (ru) | Производные витамина в6 нуклеотидов, ациклических нуклеотидов и ациклических нуклеозидных фосфонатов | |
| JP7083497B2 (ja) | がんの処置のための併用療法 | |
| JP2020504733A (ja) | テノホビルの抗ウイルス性脂肪族エステルプロドラッグ | |
| TW200844108A (en) | Compounds and pharmaceutical compositions for the treatment of liver disorders | |
| CN111093660A (zh) | 用于治疗癌症的组合疗法 | |
| IL200240A (en) | A 6-Amino-8-Hydroxy-Purine-9-Ilbenzyl Pharmaceutical Compound Conjugated with Diolauylphosphatidyl Ethanolamine | |
| JP2013531067A (ja) | 疾病及び状態の処置及び予防のためのフルオロ置換オメガ−カルボキシアリールジフェニル尿素を用いた組み合わせ薬 | |
| CN103265543A (zh) | 抑制瞬时受体电位离子通道trpa1 | |
| NO20090664L (no) | Purinderivater som A2A-agonister | |
| Durham et al. | Spray dried aerosol particles of pyrazinoic acid salts for tuberculosis therapy | |
| ES2939004T3 (es) | Derivados de pirimidina para la prevención y tratamiento de infecciones bacterianas | |
| US20190031730A1 (en) | Formulation of mk2 inhibitor peptides | |
| JP2022551477A (ja) | ４’－ハロゲン含有ヌクレオチドおよびヌクレオシド治療組成物ならびにそれらに関連する使用 | |
| CN110603038A (zh) | 雷帕霉素类似物 | |
| KR101838764B1 (ko) | (ｅ)-4-카복시스티릴-4-클로로벤질설폰의 개선된 안정한 수성 제형 | |
| AU2015292050B2 (en) | New polycrystalline form of tenofovir prodrug, and preparation method and application therefor | |
| CN102827146B (zh) | 一种氟喹诺酮醛缩异烟腙及其制备方法和应用 | |
| EP3174545A1 (de) | Effiziente hemmung von hsp27 | |
| CN105622596A (zh) | 含有烷氧亚胺基氮杂环片段的苯并噻嗪-4-酮类化合物及其制备方法 | |
| WO2019228319A1 (zh) | 基于肠道mct1载体蛋白设计的前药及其制备方法 | |
| JP2016508957A (ja) | カンジダ等の病原微生物による疾患用の医薬組成物 | |
| EP4357340A1 (en) | Salt of selective fgfr4 inhibitor, and preparation method therefor and application thereof |